Spots Global Cancer Trial Database for philadelphia chromosome positive chronic myelogenous leukemia
Every month we try and update this database with for philadelphia chromosome positive chronic myelogenous leukemia cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Interferon and GM-CSF Compared With Imatinib Mesylate and Vaccine Therapy in Patients With Chronic Phase CML on a TKI | NCT00363649 | Leukemia | GM-K562 cell va... Interferon alfa Sargramostim | 18 Years - 120 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Imatinib Mesylate After a Donor Stem Cell Transplant in Treating Patients With Philadelphia Chromosome-Positive Leukemia | NCT00244829 | Leukemia | imatinib mesyla... adjuvant therap... | - | Fred Hutchinson Cancer Center | |
| Chemotherapy and Biological Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia | NCT00003239 | Leukemia | Recombinant Int... Cytarabine Omacetaxine Mep... | 12 Years - | M.D. Anderson Cancer Center | |
| Imatinib Mesylate and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia | NCT00015847 | Leukemia | recombinant int... imatinib mesyla... | 18 Years - | OHSU Knight Cancer Institute | |
| Nilotinib and LDE225 in the Treatment of Chronic or Accelerated Phase Myeloid Leukemia in Patients Who Developed Resistance to Prior Therapy | NCT01456676 | Philadelphia Ch... | Nilotinib + LDE... | 18 Years - | Novartis | |
| Bone Marrow Transplantation in Treating Patients With Multiple Myeloma, Chronic Phase Chronic Myelogenous Leukemia, or Agnogenic Myeloid Metaplasia | NCT00004181 | Chronic Myelopr... Leukemia Multiple Myelom... | busulfan cyclophosphamid... allogeneic bone... radiation thera... | 15 Years - 55 Years | Northwestern University | |
| Chemotherapy, Filgrastim and Peripheral Stem Cell Transplantation in Patients With Chronic Myelogenous Leukemia | NCT00005986 | Leukemia | busulfan cyclophosphamid... filgrastim recombinant int... in vitro-treate... peripheral bloo... radiation thera... | 18 Years - 65 Years | Masonic Cancer Center, University of Minnesota | |
| Imatinib Mesylate After a Donor Stem Cell Transplant in Treating Patients With Philadelphia Chromosome-Positive Leukemia | NCT00244829 | Leukemia | imatinib mesyla... adjuvant therap... | - | Fred Hutchinson Cancer Center | |
| Fludarabine, Total-Body Irradiation, and Donor Stem Cell Transplant Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Chronic Myelogenous Leukemia | NCT00119340 | Leukemia | cyclosporine fludarabine pho... mycophenolate m... peripheral bloo... radiation thera... | - | Fred Hutchinson Cancer Center | |
| Irinotecan and Cytarabine in Treating Patients With Refractory or Recurrent Acute Myeloid Leukemia or Chronic Myelogenous Leukemia | NCT00053144 | Leukemia | cytarabine irinotecan hydr... | 15 Years - | Roswell Park Cancer Institute | |
| Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid Leukemia | NCT00004878 | Graft Versus Ho... Leukemia | therapeutic all... cytarabine fludarabine pho... idarubicin methotrexate tacrolimus in vitro-treate... peripheral bloo... | 50 Years - 70 Years | Jonsson Comprehensive Cancer Center | |
| Interferon and GM-CSF Compared With Imatinib Mesylate and Vaccine Therapy in Patients With Chronic Phase CML on a TKI | NCT00363649 | Leukemia | GM-K562 cell va... Interferon alfa Sargramostim | 18 Years - 120 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Imatinib Mesylate and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Myelogenous Leukemia | NCT00066326 | Leukemia | imatinib mesyla... tanespimycin | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| Irinotecan and Cytarabine in Treating Patients With Refractory or Recurrent Acute Myeloid Leukemia or Chronic Myelogenous Leukemia | NCT00053144 | Leukemia | cytarabine irinotecan hydr... | 15 Years - | Roswell Park Cancer Institute | |
| Interferon Alfa Plus Sargramostim in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia | NCT00003561 | Leukemia | recombinant int... sargramostim | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Fludarabine, Total-Body Irradiation, and Donor Stem Cell Transplant Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Chronic Myelogenous Leukemia | NCT00119340 | Leukemia | cyclosporine fludarabine pho... mycophenolate m... peripheral bloo... radiation thera... | - | Fred Hutchinson Cancer Center | |
| Vaccine Therapy and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia | NCT00301093 | Leukemia | GM-K562 cell va... imatinib mesyla... | 18 Years - | Dana-Farber Cancer Institute | |
| Imatinib Mesylate Plus Cytarabine in Treating Patients With Chronic Myelogenous Leukemia | NCT00022490 | Leukemia | cytarabine imatinib mesyla... | 18 Years - 120 Years | OHSU Knight Cancer Institute | |
| Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myeloid Leukemia | NCT00002789 | Leukemia | busulfan cyclophosphamid... cyclosporine methotrexate allogeneic bone... peripheral bloo... | 15 Years - 65 Years | Fred Hutchinson Cancer Center | |
| Chemotherapy, Filgrastim and Peripheral Stem Cell Transplantation in Patients With Chronic Myelogenous Leukemia | NCT00005986 | Leukemia | busulfan cyclophosphamid... filgrastim recombinant int... in vitro-treate... peripheral bloo... radiation thera... | 18 Years - 65 Years | Masonic Cancer Center, University of Minnesota | |
| Bone Marrow Transplantation Plus Biological Therapy in Treating Patients With Chronic Myeloid Leukemia | NCT00011934 | Leukemia | recombinant int... sargramostim autologous bone... | 12 Years - 70 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Interferon Alfa Plus Sargramostim in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia | NCT00003561 | Leukemia | recombinant int... sargramostim | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Bone Marrow Transplantation in Treating Patients With Multiple Myeloma, Chronic Phase Chronic Myelogenous Leukemia, or Agnogenic Myeloid Metaplasia | NCT00004181 | Chronic Myelopr... Leukemia Multiple Myelom... | busulfan cyclophosphamid... allogeneic bone... radiation thera... | 15 Years - 55 Years | Northwestern University | |
| Sargramostim Following Allogeneic Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia | NCT00002778 | Leukemia | sargramostim therapeutic all... allogeneic bone... in vitro-treate... | 18 Years - 65 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Imatinib Mesylate Plus Cytarabine in Treating Patients With Chronic Myelogenous Leukemia | NCT00022490 | Leukemia | cytarabine imatinib mesyla... | 18 Years - 120 Years | OHSU Knight Cancer Institute | |
| Chemotherapy and Peripheral Stem Cell Transplantation Followed by Immunotherapy in Treating Patients With Chronic Myelogenous Leukemia | NCT00003727 | Leukemia | filgrastim recombinant int... sargramostim therapeutic aut... carmustine cyclophosphamid... etoposide gemcitabine hyd... melphalan bone marrow abl... in vitro-treate... | - 120 Years | University of Maryland, Baltimore | |
| Chemotherapy and Biological Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia | NCT00003239 | Leukemia | Recombinant Int... Cytarabine Omacetaxine Mep... | 12 Years - | M.D. Anderson Cancer Center | |
| Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myeloid Leukemia | NCT00002789 | Leukemia | busulfan cyclophosphamid... cyclosporine methotrexate allogeneic bone... peripheral bloo... | 15 Years - 65 Years | Fred Hutchinson Cancer Center | |
| Bone Marrow Transplantation in Treating Patients With Multiple Myeloma, Chronic Phase Chronic Myelogenous Leukemia, or Agnogenic Myeloid Metaplasia | NCT00004181 | Chronic Myelopr... Leukemia Multiple Myelom... | busulfan cyclophosphamid... allogeneic bone... radiation thera... | 15 Years - 55 Years | Northwestern University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
